Mysterious Outbreak Climbs — Source Still Sprays
A fifth New Yorker has died from Legionnaires' disease as an outbreak tied to contaminated cooling towers keeps growing on Manhattan's Upper East Side.
Story...
ER Surge From Ticks Alarms Doctors
Tick season is not just annoying this year; the early numbers suggest it is hitting emergency rooms harder than usual, especially in the Northeast.
Quick...
Million-Bottle Recall Raises Alarms
Nearly 1 million bottles of trusted heart and kidney drugs were yanked off shelves because of mystery specks no one will fully explain.
Story Snapshot
...
TODAY: Huge $50 Drug Deal Hits Medicare
For the first time, Medicare is paying for powerful weight-loss drugs—but only through a strict, temporary “Bridge” that could reshape both senior health and...
VIDEO: FDA Move Applauded By Pet Owners
A fast-acting flea pill just became an emergency lifeline against flesh-eating worms in America’s pets.
Story Snapshot
The Food and Drug Administration (FDA) authorized nitenpyram...
Miracle Pill? Cancer Docs Stunned By ‘Impossible’ Gains
A pill that targets one rogue protein just bought some pancreatic cancer patients an extra half-year of life—and that quietly rewrites what doctors thought...
CDC Director Shrugs Off Deadly Virus
A virus that kills one in three infected people just sailed into the Atlantic on a cruise ship, and America's top disease expert says...
Prior Authorization Rollback Applauded by Patients
UnitedHealthcare just did something rare in American healthcare: it cut red tape in a way you can actually measure.
Story Snapshot
UnitedHealthcare says it has...
Amazon’s GLP-1 Speed Play Stuns Pharmacies
Amazon’s real breakthrough isn’t an “Ozempic pill”—it’s turning a doctor visit, prescription, and pickup into something that feels as frictionless as buying batteries.
Story Snapshot
...
Amazon’s Weight-Loss Push Raises Red Flags
Amazon just turned a prescription weight-loss drug into something that can feel as easy as ordering batteries—and that convenience will reshape who gets these...
